Edition:
United Kingdom

Aptose Biosciences Inc (APTO.OQ)

APTO.OQ on NASDAQ Stock Exchange Capital Market

2.32USD
22 Aug 2019
Change (% chg)

$-0.06 (-2.52%)
Prev Close
$2.38
Open
$2.36
Day's High
$2.42
Day's Low
$2.32
Volume
29,319
Avg. Vol
60,630
52-wk High
$3.19
52-wk Low
$1.58

About

Aptose Biosciences Inc. (Aptose) is a clinical-stage biotechnology company. The Company is engaged in the development of anticancer drugs that target specific epigenetic processes and signal transduction abnormalities that underlie a particular life-threatening malignancy. Its product pipeline includes cancer drug candidates... (more)

Overall

Beta: 2.10
Market Cap(Mil.): $33.86
Shares Outstanding(Mil.): 24.17
Dividend: --
Yield (%): --

Financials

  APTO.OQ Industry Sector
P/E (TTM): -- 69.38 32.67
EPS (TTM): -0.80 -- --
ROI: -123.77 8.95 14.48
ROE: -123.77 10.09 15.78
Reuters.com is improving our Quote page. Click here to take a look and let us know what you think.

Earnings vs. Estimates